Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase NA 2Phase EARLY_PHASE1 2Phase 4 1Phase 3 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Multiple Myeloma 13Recurrence 9Neoplasms 8Colorectal Neoplasms 8Pancreatic Neoplasms 7Leukemia, Myeloid, Acute 7Hematologic Neoplasms 7Carcinoma, Hepatocellular 7Lymphoma, B-Cell 6Sarcoma 5Prostatic Neoplasms 5Breast Neoplasms 5Neoplasms, Plasma Cell 4Myasthenia Gravis 4Lymphoma 4Lung Neoplasms 4Glioblastoma 4Burkitt Lymphoma 4Brain Neoplasms 4Advanced Solid Tumors 4Stomach Neoplasms 3Solid Tumor 3Ovarian Neoplasms 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Head and Neck Neoplasms 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Not yet recruiting × NSCLC × Clear all
NCT06735508 2024-12-16

MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

Guangdong Provincial People's Hospital

Phase EARLY_PHASE1 Not yet recruiting
40 enrolled
Thoracic

NSCLC

NCT06685653 2024-11-12

Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients

Nanjing Tianyinshan Hospital

Phase EARLY_PHASE1 Not yet recruiting
65 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡